Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease

► NonaMen has the potential to broadly protect against MenB disease. ► Nonamen was considered effective and safe in rabbits and mice. ► Risks-benefit balance favors use of plain NonaMen without an aluminium adjuvant.